In 2021, the global ticagrelor market stood at USD 1,422 million. Recording a CAGR of 6.8% from 2022 to 2028, the worth is projected to reach ~USD 2,254 million by 2028, according to a new report by Gen Consulting Company.
This industry report offers market estimates of the global market, followed by a detailed analysis of the dosage, route of administration, application, end user, and region. The global market data on ticagrelor can be segmented by dosage: 90mg, 60mg. Ticagrelor market is further segmented by route of administration: nasogastric tube, oral. Based on application, the ticagrelor market is segmented into: acute coronary syndrome, cardiac surgery. On the basis of end user, the ticagrelor market also can be divided into: ambulatory surgery centers (ASCs), hospitals & clinics, others. Ticagrelor market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW).
The competitive landscape of the market is highly consolidated and dominated by key players such as AstraZeneca plc.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
– Get a detailed picture of the Global Ticagrelor Market
– Identify segments/areas to invest in over the forecast period in the Global Ticagrelor Market
– Understand the competitive environment, the market’s leading players
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2021 |
| Forecast Year | 2022-2028 |
| CAGR (2022-2028) | 6.8% |
| Pages | 20 |
| Key Players | AstraZeneca plc |
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
According to the latest estimates, the global diagnostic enzymes market is predicted to be growing at a CAGR of over 4.1% from 2023 to 2029. Diagnostic enzymes are a crucial…
Please fill out our form and we will get back to you.